Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Scientists Prepare Disposable Lab-on-a-Chip for Diagnosis at POC

By LabMedica International staff writers
Posted on 01 Oct 2008
Low-cost, disposable cartridges would allow doctors to perform diagnostic tests at the point-of-care and speed up diagnosis and treatment.

European scientists are rapidly approaching their goal of producing a polymer-based device the size of a credit card that would be able to control the movement of biologic fluids, detect the presence of specific proteins, for example early signs of cancer, and analyze the results.

Scientists from Surface Enhanced Micro Optical Fluidic Systems, a consortium of multidisciplinary expertise divided among eight partners and five European countries, are working towards their goal of low cost disposable cartridges capable of quickly and accurately performing complex medical diagnostic tests. More...


The SEMOFS scientists reported that it has made the greatest progress in two areas--microfluidics and plasmonics. Microfluidics includes techniques for controlling the movement of minute quantities of fluids. The SEMOFS card moves blood, serum, and other fluids through channels slightly wider than a human hair. Once the biologic sample and the fluids necessary to process it have interacted in the proper sequence, the device uses plasmonics to determine if proteins from the sample have bonded to the detecting surfaces inside the card.

The scientists plan to pack everything, light sources and detector, waveguides, and the microfluidic system, into one polymer-based card. The electronics that will read the cards and display the results will be a separate unit. "We are targeting state-of-the-art sensitivities or better,” stated Jerôme Gavillet, the dissemination coordinator of SEMOFS, "in a system that could be available anywhere for less than EUR 50.”

Related Links:
SEMOFS



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.